Background. There is no standard definition for “HLA incompatible” transplants. For the first
time, we systematically assessed how HLA incompatibility was defined in contemporary …

Abstract Donor-specific antibody (DSA), particularly against HLA class II, is a major cause of
chronic antibody-mediated rejection (CAMR) after transplantation, although ABO …

Background Chronic antibody-mediated rejection (cAMR) is the leading cause of late kidney
graft loss, but current therapies are often ineffective. Rabbit anti-human thymocyte …

Optimal induction strategy in highly sensitized kidney transplant recipients (KTRs) is still a
matter of debate. The place of therapies, such as plasma exchange and rituximab, with …

Early outcomes following solid organ transplantation have markedly improved in recent
years. Antibody-mediated rejection caused by donor specific anti-human leukocyte antigen …

Renal transplantation is widely accepted as the best therapeutic treatment modality for the
patients with end stage renal disease. However sensitization to previous antigen exposure …

Immunoglobulins have long been established as important mediators of adaptive immunity,
providing specific and potent response to mitigate any immunogenic threat. The therapeutic …

Most kidney transplant centers in the United States of America currently exclude all potential
recipients with a donor-specific antibody (DSA), by listing them as unacceptable human …

Background Chronic antibody-mediated rejection (cAMR) is the leading cause of late kidney
graft loss, but current therapies are often ineffective. Rabbit anti-human thymocyte …

Darbo tikslas: įvertinti inkstų recipientų ikitransplantacinį įsijautrinimą ŽLA sistemos
antigenams. Uždaviniai: 1. Nustatyti ir įvertinti antikūnų prieš ŽLA sistemos I ir II klasės …